JP2023504282A5 - - Google Patents

Info

Publication number
JP2023504282A5
JP2023504282A5 JP2022534255A JP2022534255A JP2023504282A5 JP 2023504282 A5 JP2023504282 A5 JP 2023504282A5 JP 2022534255 A JP2022534255 A JP 2022534255A JP 2022534255 A JP2022534255 A JP 2022534255A JP 2023504282 A5 JP2023504282 A5 JP 2023504282A5
Authority
JP
Japan
Prior art keywords
emulsion
therapeutic protein
nanospheres
cytokine
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022534255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504282A (ja
JP7818514B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063314 external-priority patent/WO2021113638A1/en
Publication of JP2023504282A publication Critical patent/JP2023504282A/ja
Publication of JP2023504282A5 publication Critical patent/JP2023504282A5/ja
Priority to JP2026019595A priority Critical patent/JP2026077709A/ja
Application granted granted Critical
Publication of JP7818514B2 publication Critical patent/JP7818514B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022534255A 2019-12-05 2020-12-04 タンパク質を搭載したplgaナノスフィア Active JP7818514B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026019595A JP2026077709A (ja) 2019-12-05 2026-02-09 タンパク質を搭載したplgaナノスフィア

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962944191P 2019-12-05 2019-12-05
US62/944,191 2019-12-05
PCT/US2020/063314 WO2021113638A1 (en) 2019-12-05 2020-12-04 Protein-loaded plga nanospheres

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026019595A Division JP2026077709A (ja) 2019-12-05 2026-02-09 タンパク質を搭載したplgaナノスフィア

Publications (3)

Publication Number Publication Date
JP2023504282A JP2023504282A (ja) 2023-02-02
JP2023504282A5 true JP2023504282A5 (cg-RX-API-DMAC7.html) 2023-12-12
JP7818514B2 JP7818514B2 (ja) 2026-02-20

Family

ID=76221229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022534255A Active JP7818514B2 (ja) 2019-12-05 2020-12-04 タンパク質を搭載したplgaナノスフィア
JP2026019595A Pending JP2026077709A (ja) 2019-12-05 2026-02-09 タンパク質を搭載したplgaナノスフィア

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026019595A Pending JP2026077709A (ja) 2019-12-05 2026-02-09 タンパク質を搭載したplgaナノスフィア

Country Status (11)

Country Link
US (3) US12214046B2 (cg-RX-API-DMAC7.html)
EP (1) EP4072536A4 (cg-RX-API-DMAC7.html)
JP (2) JP7818514B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220143811A (cg-RX-API-DMAC7.html)
CN (1) CN115335041A (cg-RX-API-DMAC7.html)
AU (1) AU2020396557B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022010952A2 (cg-RX-API-DMAC7.html)
CA (1) CA3160922A1 (cg-RX-API-DMAC7.html)
IL (1) IL293607A (cg-RX-API-DMAC7.html)
MX (1) MX2022006824A (cg-RX-API-DMAC7.html)
WO (1) WO2021113638A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022006824A (es) 2019-12-05 2022-09-19 Univ West Virginia Nanoesferas de plga cargadas con proteinas.
CN116855571B (zh) * 2023-06-26 2025-03-21 中国农业大学 Plga纳米球病毒示踪剂及其制备方法与应用
KR20250069077A (ko) * 2023-11-10 2025-05-19 아주대학교산학협력단 패티케이션 기술을 적용한 쿠에티아핀-지방산 접합체 나노입자 및 이의 장기 지속형 주사제 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
FR2793684B1 (fr) 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US20040003402A1 (en) 2002-06-27 2004-01-01 Digeo, Inc. Method and apparatus for automatic ticker generation based on implicit or explicit profiling
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
WO2005023293A1 (en) * 2003-09-09 2005-03-17 Pohang University Of Science And Technology Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
KR100622996B1 (ko) * 2005-03-03 2006-09-14 한국과학기술원 약물이 봉입된 비다공성 고분자 미립 담체 및 이의 제조방법
EP1985309B1 (en) 2005-12-26 2016-11-23 LTT Bio-Pharma Co., Ltd. Nanoparticles containing water-soluble non-peptide low-molecular weight drug
US10265407B2 (en) 2007-02-15 2019-04-23 Yale University Modular nanodevices for smart adaptable vaccines
DK2251006T3 (en) 2008-02-22 2017-10-16 Toray Industries Microparticles and pharmaceutical compositions thereof
US9972047B1 (en) 2008-04-18 2018-05-15 Capital One Services, Llc Systems and methods for performing a purchase transaction using rewards points
US20090281888A1 (en) 2008-05-09 2009-11-12 Li-Cheng Richard Zai Method And Apparatus For Establishing Time-Based Loyalty Relationship
AU2009268923B2 (en) 2008-06-16 2015-09-17 Pfizer Inc. Drug loaded polymeric nanoparticles and methods of making and using same
MX2011005672A (es) * 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
WO2011063177A1 (en) 2009-11-20 2011-05-26 Mobisave Corporation System and method of electronically verifying required proof-of-performance to secure promotional rewards
US8207290B2 (en) 2010-03-26 2012-06-26 Cerulean Pharma Inc. Methods and systems for generating nanoparticles
WO2012051220A1 (en) * 2010-10-11 2012-04-19 Wichita State University Composite magnetic nanoparticle drug delivery system
RU2014112958A (ru) * 2011-09-21 2015-10-27 Йиссум Ресерч Девелопмент Компани оф де Хебрю Юниверсити оф Джерусалем Лтд. Наносистемы доставки для мирнк
US9562015B2 (en) * 2011-11-17 2017-02-07 The Regents Of The University Of Colorado, A Body Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
US9610250B2 (en) * 2012-04-12 2017-04-04 Yale University Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
US10555911B2 (en) 2012-05-04 2020-02-11 Yale University Highly penetrative nanocarriers for treatment of CNS disease
US9724304B2 (en) 2012-06-14 2017-08-08 Temple University—Of the Commonwealth System of Higher Education Nanospheres for therapeutic agent delivery
US9308172B2 (en) 2012-10-26 2016-04-12 Board Of Trustees Of Michigan State University Device and method for encapsulation of hydrophilic materials
KR20190126452A (ko) * 2013-11-01 2019-11-11 예일 유니버시티 면역요법용 모듈러 입자
US10272050B2 (en) * 2014-10-14 2019-04-30 The Brigham And Women's Hospital, Inc. Nanoparticles and methods of use
CN104622795B (zh) * 2015-01-28 2017-12-08 杭州市萧山区中医院 一种多细胞因子序贯缓释微球‑水凝胶复合系统及其制备方法
AU2016251687C1 (en) 2015-04-22 2023-07-27 CureVac SE RNA containing composition for treatment of tumor diseases
US20170056327A1 (en) * 2015-08-25 2017-03-02 The Methodist Hospital Micro/nano composite drug delivery formulations and uses thereof
KR102717886B1 (ko) * 2018-02-26 2024-10-16 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 약물 전달 시스템
CA3141275A1 (en) 2019-06-18 2020-12-24 Biomeme, Inc. Systems for sample analysis
MX2022006824A (es) 2019-12-05 2022-09-19 Univ West Virginia Nanoesferas de plga cargadas con proteinas.

Similar Documents

Publication Publication Date Title
CN1132625C (zh) 包胶在透明质酸微粒中的缓释药物组合物
JP3802348B2 (ja) タンパク質薬物または抗原を含む、親油性微細粒子およびそれを含む剤形
US20250064949A1 (en) Protein-loaded plga nanospheres
JPS63239212A (ja) パルス的かつ持続放出性製剤
JPH09506866A (ja) 医薬として活性のある物質の免疫療法のための放出制御
JP2011046742A (ja) 腫瘍ワクチン
CN1549728A (zh) 在可生物降解的微球体中含有抗原、基因载体和佐剂的免疫组合物
EP1638534B1 (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
JP2023548560A5 (cg-RX-API-DMAC7.html)
Karem et al. Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains
CN1343125A (zh) 癌症治疗中的免疫刺激剂细菌膜组分
JPH03502574A (ja) メチルセルロース製薬学的組成物
JP3492671B2 (ja) 免疫アジュバント
CN108339116B (zh) 壬二酸的应用、含有壬二酸的佐剂和疫苗剂
CN1692943A (zh) CpG DNA分子抗感染免疫制剂的制备和应用
JP2001010961A (ja) 腫瘍ワクチン
HK40083735A (en) Protein-loaded plga nanospheres
EP2925297B1 (en) Composition comprising cytokine macro-aggregates
CN116712565A (zh) 一种口服胃癌疫苗
CN119158014A (zh) 一种双佐剂组合物及其在制备犬、猫狂犬病灭活疫苗中的应用
CN118787606A (zh) 白介素2酵母微囊口服靶向药物递送系统及其制备方法和用途
CN1720922A (zh) CpG寡聚核苷酸抗感染DNA制剂的制备及应用技术
CN116115565A (zh) 一种plga纳米乳及其制备和在副结核疫苗中的应用
CN119818662A (zh) 一种丝胶磷酸钙纳米肿瘤疫苗的制备方法及其应用
HK1089954B (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix